1. Home
  2. ALT vs LMNR Comparison

ALT vs LMNR Comparison

Compare ALT & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • LMNR
  • Stock Information
  • Founded
  • ALT 1997
  • LMNR 1893
  • Country
  • ALT United States
  • LMNR United States
  • Employees
  • ALT N/A
  • LMNR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • LMNR Farming/Seeds/Milling
  • Sector
  • ALT Health Care
  • LMNR Consumer Staples
  • Exchange
  • ALT Nasdaq
  • LMNR Nasdaq
  • Market Cap
  • ALT 333.6M
  • LMNR 292.4M
  • IPO Year
  • ALT N/A
  • LMNR N/A
  • Fundamental
  • Price
  • ALT $3.93
  • LMNR $14.73
  • Analyst Decision
  • ALT Strong Buy
  • LMNR Buy
  • Analyst Count
  • ALT 6
  • LMNR 2
  • Target Price
  • ALT $17.40
  • LMNR $20.50
  • AVG Volume (30 Days)
  • ALT 3.0M
  • LMNR 61.8K
  • Earning Date
  • ALT 11-11-2025
  • LMNR 09-09-2025
  • Dividend Yield
  • ALT N/A
  • LMNR 2.04%
  • EPS Growth
  • ALT N/A
  • LMNR N/A
  • EPS
  • ALT N/A
  • LMNR N/A
  • Revenue
  • ALT $20,000.00
  • LMNR $160,763,000.00
  • Revenue This Year
  • ALT N/A
  • LMNR N/A
  • Revenue Next Year
  • ALT N/A
  • LMNR N/A
  • P/E Ratio
  • ALT N/A
  • LMNR N/A
  • Revenue Growth
  • ALT N/A
  • LMNR N/A
  • 52 Week Low
  • ALT $2.90
  • LMNR $14.40
  • 52 Week High
  • ALT $11.16
  • LMNR $29.22
  • Technical
  • Relative Strength Index (RSI)
  • ALT 52.80
  • LMNR 44.70
  • Support Level
  • ALT $3.85
  • LMNR $14.75
  • Resistance Level
  • ALT $4.06
  • LMNR $15.30
  • Average True Range (ATR)
  • ALT 0.20
  • LMNR 0.30
  • MACD
  • ALT 0.02
  • LMNR 0.01
  • Stochastic Oscillator
  • ALT 57.35
  • LMNR 42.26

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

Share on Social Networks: